Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s): MDXXF

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.

CSE:MDMA - Post by User

Pharmala Biotech Holdings Inc > Horizens Psychedelics ETF is closing this month

<< Previous

Bullboard Posts

Next >>

Comment by inviolablspiriton Mar 19, 2024 1:48pm

81 Views

Post# 35941069

RE:RE:RE:Horizens Psychedelics ETF is closing this month

Sorry, my mistake 1.49% of the Horizons ETF fund would be about 950 000 shares of MDMA left to sell at the current price of 15.5 cents. So they are certainly not done selling shares and the pressure continues as the fund is delisted on Friday and closed down on March 28.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?